Search for: "Bailey v. Bailey" Results 141 - 160 of 1,362
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Feb 2022, 12:24 am by INFORRM
On 16 February 2022, the Supreme Court handed down its judgment in ZXC v Bloomberg [2022] UKSC 5. [read post]
4 Feb 2022, 10:56 am by Thaddeus Hoffmeister
Defense Attorney’s Interjection of Racial Stereotypes During Jury Selection Leads to Conviction Reversal In Dean v. [read post]
16 Jan 2022, 4:22 pm by INFORRM
IPSO 043659-21 Brundrett & Bailey v Mail Online, 1 Accuracy (2019), Breach – sanction: action as offered by publication 04370-21 Brundrett & Bailey v Daily Star, 1 Accuracy (2012), Breach – sanction: action as offered by the publication 07583-21 Mitchell v Stornoway Gazette, 1 Accuracy (2019), Breach – sanction: action as offered by publication New Issued Cases There were two new cases issued in the last week, both were Norwich… [read post]
10 Jan 2022, 4:01 pm by INFORRM
IPSO Decisions since the last round up 07468-21 Couzens v Mail Online, 2 Privacy (2019), 6 Children (2019, No breach – after investigation 06399-21 Brace v thejc.com, 1 Accuracy (2021), Breach – sanction: action as offered by publication 08032-21 Doherty v Ardrossan & Saltcoats, 1 Accuracy (2019), Breach – saction: publication of adjudication 04367-21 Brundrett & Bailey v derbytelegraph.co.uk, 1 Accuracy (2019), No breach… [read post]
28 Dec 2021, 4:25 pm by INFORRM
Although it was media attention on the Viral Video that first propelled the Claimant (and Bailey McLaren) into the glare of publicity, overwhelmingly that coverage (rightly) portrayed the Claimant as the victim in the Playing Field Incident. [read post]
1 Dec 2021, 1:29 pm by Kevin LaCroix
In the following guest post, Tony Kriesel, Claims Specialist with IQUW; Elan Kandel, a Member of the Bailey Cavalieri law firm; and James Talbert, an Associate at Bailey Cavalieri, take a look at the reasons for the pharmaceutical industry’s high securities litigation frequency experience and at the implications of the lawsuit frequency for pharmaceutical companies and their insurers. [read post]